Abstract
Background: Several demographic, environmental and clinical risk factors have been determined as possible risk/protective factors of Alzheimers disease (AD). The purpose of this study was to find out which one of these known factors is related to developing of AD in Iranian population. Materials and Methods: In a case-control study, 115 elderly patients (mean age of 70±8.18 years) with DSM-IV based final diagnosis compared with 115 non-demented counterparts matched for age ,sex, and socioeconomic status regarding lifestyle, family history, and history of bio-psychosocial health. Results: All differences between the two groups were non-significant except for history of hypertension (P=0.018) which was most prevalent in AD group. Risk of the incident AD for the hypertensive group was 1.71 (1.08-2.70) compared to the non-hypertensive group. Conclusion: These results confirm the previously reported relationship between AD and vascular factors. Prevention, early detection, and treatment of hypertension may have some implications in the primary and secondary prevention of AD.
Keywords: Alzheimer's disease, Risk factors, Hypertension, Smoking, Diabetes mellitus
Current Alzheimer Research
Title: Risk Factors of Alzheimers Disease Among Iranian Population
Volume: 5 Issue: 1
Author(s): Mahshid Foroughan, Zia Ghaemmagham Farahani, Maryam Shariatpanahi, Mehrak Vaezinejad, Ahmad Ali Akbari Kamerani and Mehrdad Sheikhvatan
Affiliation:
Keywords: Alzheimer's disease, Risk factors, Hypertension, Smoking, Diabetes mellitus
Abstract: Background: Several demographic, environmental and clinical risk factors have been determined as possible risk/protective factors of Alzheimers disease (AD). The purpose of this study was to find out which one of these known factors is related to developing of AD in Iranian population. Materials and Methods: In a case-control study, 115 elderly patients (mean age of 70±8.18 years) with DSM-IV based final diagnosis compared with 115 non-demented counterparts matched for age ,sex, and socioeconomic status regarding lifestyle, family history, and history of bio-psychosocial health. Results: All differences between the two groups were non-significant except for history of hypertension (P=0.018) which was most prevalent in AD group. Risk of the incident AD for the hypertensive group was 1.71 (1.08-2.70) compared to the non-hypertensive group. Conclusion: These results confirm the previously reported relationship between AD and vascular factors. Prevention, early detection, and treatment of hypertension may have some implications in the primary and secondary prevention of AD.
Export Options
About this article
Cite this article as:
Foroughan Mahshid, Farahani Ghaemmagham Zia, Shariatpanahi Maryam, Vaezinejad Mehrak, Akbari Kamerani Ali Ahmad and Sheikhvatan Mehrdad, Risk Factors of Alzheimers Disease Among Iranian Population, Current Alzheimer Research 2008; 5 (1) . https://dx.doi.org/10.2174/156720508783884594
DOI https://dx.doi.org/10.2174/156720508783884594 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Rationally Designed Multitarget Agents Against Inflammation and Pain
Current Medicinal Chemistry Imidazoline Receptor Agonists for Managing Hypertension May Hold Promise for Treatment of Intracerebral Hemorrhage
Current Molecular Medicine The Polymorphism at the microRNA-155 Binding Site in the AGTR1 Gene is not Significantly Associated with Rheumatic Heart Disease in Saudi Arabia Population
MicroRNA Subject index to volume 3
Current Molecular Medicine Neurodegenerative Diseases of the Retina and Potential for Protection and Recovery
Current Neuropharmacology Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome
Current Pharmaceutical Design Non-Infectious Complications of Immunosuppressant Medications in Renal Transplant Patients
Current Clinical Pharmacology Current Options for the Pharmacotherapy of Obesity
Current Pharmaceutical Design Editorial [Concurrent Blood Pressure, Glycemic and Lipid Control for the Prevention of Vascular Complications of Type II Diabetes Mellitus: A Long Overdue Objective?]
Current Vascular Pharmacology Predictive Factors of follow-up Non-attendance and Mortality Among Adults with Type 2 Diabetes Mellitus- an Analysis of the Malaysian Diabetes Registry 2009
Current Diabetes Reviews Serelaxin: New Investigational Treatment in Acute Heart Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry Natural Polyphenols in the Treatment of Alzheimer’s Disease
Current Drug Targets The anti-inflammatory agents Siblings Nitroxyl (HNO) and Nitric Oxide (NO) in Cardioprotection
Drug Design Reviews - Online (Discontinued) Circulating Endothelial Progenitor Cells Characterization, Function and Relationship with Cardiovascular Risk Factors
Current Pharmaceutical Design Dietary Antioxidants as Potential Pharmacological Agents for Ischemic Stroke
Current Medicinal Chemistry Teaching a Lifestyle Intervention for Reversing Impaired Fasting Glucose, Hyperlipidemia and Obesity/Overweight to a Cohort of Local Physicians
Current Nutrition & Food Science Transdermal Delivery of Lercanidipine Hydrochloride: Effect of Chemical Enhancers and Ultrasound
Current Drug Delivery Insulin, Thrombin, ERK1/2 Kinase and Vascular Smooth Muscle Cells Proliferation
Current Pharmaceutical Design Lipoxins, The Novel Mediators of Gastroprotection and Gastric Adaptation to Ulcerogenic action of Aspirin
Current Pharmaceutical Design Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?
Current Molecular Pharmacology